Bethesda-based Northwest Biotherapeutics raised $27 million in a secondary offering of common stock and warrants. The gross proceeds includes $3.5 million in over-allotments bought by underwriters. The company has 44 million shares outstanding and a market capitalization of $215 million.
Help employers find you! Check out all the jobs and post your resume.
